Lv6
1740 积分 2023-12-22 加入
Phase Ib study of anlotinib in combination with anti-PD-L1 antibody (TQB2450) in patients with advanced acral melanoma
19天前
已完结
Real-World Outcomes of Patients Treated With Gemcitabine Using Standardized Dose and Rate and Docetaxel for Advanced Soft Tissue Sarcoma in an Australian Sarcoma Center
2个月前
已完结
Apatinib with doxorubicin and ifosfamide as neoadjuvant therapy for high-risk soft tissue sarcomas: a retrospective cohort study
2个月前
已完结
A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
2个月前
已完结
Multicenter, Randomized, Phase III Trial of Neoadjuvant Chemoradiation With Capecitabine and Irinotecan Guided by UGT1A1 Status in Patients With Locally Advanced Rectal Cancer
3个月前
已完结
Sintilimabplusanlotinibinpatientswithpre-treatedlocallyadvancedormetastaticsarcoma:aprospectivesingle-armphaseIIclinicaltrial
3个月前
已完结
First-Line of Anlotinib Plus Anthracyclines and Ifosfamide Followed by Anlotinib Maintenance in Advanced Soft Tissue Sarcoma: A Phase II Single-Arm Trial
4个月前
已完结
Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcoma: A Systematic Review
4个月前
已完结
皖公网安备34019202002308
